Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six-month results of a randomized, double-blind, controlled trial-Reference-Cited by-同舟云学术

Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six-month results of a randomized, double-blind, controlled trial

Published:2009-10-29 Issue:11 Volume:60 Page:3346-3355
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Saag Kenneth G.,Zanchetta Jose R.,Devogelaer Jean-Pierre,Adler Robert A.,Eastell Richard,See Kyoungah,Krege John H.,Krohn Kelly,Warner Margaret R.

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference33 articles.

1. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update;American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis;Arthritis Rheum,2001

2. Glucocorticoid-induced osteoporosis;Saag;Endocrinol Metab Clin North Am,2003

3. Glucocorticoid-induced osteoporosis: pathophysiology and therapy;Canalis;Osteoporos Int,2007

4. Clinical review 151-the role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: a re-examination of the evidence;Rubin;J Clin Endocrinol Metab,2002

5. Use of oral corticosteroids and risk of fractures;Van Staa;J Bone Miner Res,2000

Cited by 404 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic glucocorticoid therapy for SLE;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Cushing’s disease and bone;Pituitary;2024-07-15

3. Clinical practice guideline for the prevention, diagnosis, and treatment of glucocorticoid-induced osteoporosis. Colombian Association of Rheumatology, 2023;Revista Colombiana de Reumatología (English Edition);2024-07

4. Romosozumab versus parathyroid hormone receptor agonists: which osteoanabolic to choose and when?;European Journal of Endocrinology;2024-06-28

5. Guidelines for fracture risk assessment and management of osteoporosis in postmenopausal women and men above the age of 50 in Qatar;Archives of Osteoporosis;2024-05-02